Skip to main content
Graduate School of Biomedical Sciences

Recent Publications from the Vary Lab

Beauchemin M, Geguchadze R, Guntur AR, Nevola K, Le PT, Barlow D, Rue M, Vary CPH, Lary CW, Motyl KJ, Houseknecht KL. 2019. Exploring mechanisms of increased cardiovascular disease risk with antipsychotic medications: Risperidone alters the cardiac proteomic signature in mice. Pharmacol Res. 21:104589. doi: 10.1016/j.phrs.2019.104589. Abstract

Peterson SM, Turner JE, Harrington A, Davis-Knowlton J, Lindner V, Gridley T, Vary CPH, Liaw L. 2018. Notch2 and proteomic signatures in mouse neointimal lesion formation. Arterioscler Thromb Vasc Biol. 8: 1576-1593.. Abstract

Fairfield H, Falank C, Farrell M, Vary C, Boucher JM, Driscoll H, Liaw L, Rosen CJ, Reagan MR. 2018. Development of a 3D bone marrow adipose tissue model. Bone Epub ahead of print. Abstract

Li P, Karaczyn AA, McGlauflin R, Favreau A, Jachimowicz E, Vary C, Xu K, Wojchowski DM, Sathyanarayana. 2017. Novel roles for podocalyxin in regulating stress myelopoiesis, Rap1a and neutrophil migration. Exp Haematol. 50: 77-83. Abstract

Uygur B, Abramo K, Leikina E, Vary C, Liaw L, Wu WS. 2015. SLUG is a direct transcriptional repressor of PTEN tumor suppressor. Prostate 75: 907-916. Abstract

Rostama B, Peterson SM, Vary CPH, Liaw L. 2014. Notch signal integration in the vasculature during remodeling.  J Vasc Pharmacol. 63: 97-114.Abstract

Contois LW, Akalu A, Caron JM, Tweedie E, Cretu A, Henderson T, Liaw L, Friesel R, Vary C, Brooks PC. 2015. Inhibition of tumor-associated αvβ3 integrin regulates the angiogenic switch by enhancing expression of IGFBP-4 leading to reduced melanoma growth and angiogenesis in vivo. Angiogenesis 18: 31-46. Abstract

Breen MJ, Moran DM, Liu W, Huang X, Vary CP, Bergan RC. 2013. Endoglin-mediated suppression of prostate cancer invasion is regulated by activin and bone morphogenetic protein type II receptors. PLoS One 8: e72407. Abstract

Duarte CW, Murray K, Lucas FL, Fairfield K, Miller H, Brooks P, Vary CP. 2013. Improved survival outcomes in cancer patients with hereditary hemorrhagic telangiectasia. Cancer Epidemiol Biomarkers Prev. 23: 117-125.  Abstract

Favreau AJ, Vary CP, Brooks PC, Sathyanarayana P. Cryptic collagen IV promotes cell migration and adhesion in myeloid leukemia. Cancer Med. 3: 265-272.  Abstract

Gong Y, Yang X, He Q, Gower L, Prudovsky I, Vary CP, Brooks PC, Friesel RE. 2013. Sprouty4 regulates endothelial cell migration via modulating integrin β3 stability through c-Src. Angiogenesis 16: 861-875.  Abstract

Young K, Conley B, Romero D, Tweedie E, O'Neill C, Pinz I, Brogan L, Lindner V, Liaw L, Vary CP. 2012. BMP9 regulates endoglin-dependent chemokine responses in endothelial cells. Blood 120: 4263-4273. Abstract

Contois LW, Nugent DP, Caron JM, Cretu A, Tweedie E, Akalu A, Liebes L, Friesel R, Rosen C, Vary C, Brooks PC. 2012. Insulin-like growth factor binding protein-4 differentially inhibits growth factor-induced angiogenesis. J Biol Chem. 287: 1779-1789. Abstract